Prof Jennifer Keiser
Jennifer Keiser heads the Helminth Drug Development Unit at Swiss TPH, which maintains a large and unique set of helminth-rodent models. She is a Professor of Neglected Tropical Diseases at the Faculty of Science of the University of Basel. Research objectives of her team include in vitro and in vivo evaluation of biological activities of chemical compounds, assay development, preclinical studies such as pharmacokinetics and metabolism, and clinical trials in helminthiasis-endemic countries, particularly in Côte d’Ivoire, Lao People’s Democratic Republic, Russia and Tanzania. Keiser holds a 5-year ERC Advanced grant and leads a 5-year multi-partner EU grant to develop new drugs against neglected helminth infections.